We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Zinc-Based Dissolvable Implants to Transform Bone Repair

By HospiMedica International staff writers
Posted on 14 Feb 2025

Surgeons commonly use orthopedic implants made from stainless steel or titanium, which remain in the body indefinitely. More...

These implants can cause discomfort and may necessitate follow-up surgeries. Zinc is gaining attention as a key material for next-generation biodegradable implants. However, its natural softness limits its application in load-bearing orthopedic implants. A newly developed zinc alloy may address these challenges by offering mechanical strength while being gentle enough to degrade safely over time, providing support for optimal healing.

New research at Monash University (Melbourne, VIC, Australia) has the potential to revolutionize the treatment of broken bones. The researchers developed a unique zinc-based dissolvable material that could replace the metal plates and screws traditionally used to stabilize fractured bones. Their study, published in Nature, highlights an innovative approach by a team of biomedical engineers who engineered a zinc alloy strong enough to match the durability of permanent steel implants and more robust than other biodegradable materials, such as magnesium-based implants.

The study reveals that by manipulating the size and alignment of the material’s grains, the zinc alloy can bend and adjust in ways that align with the shape of surrounding tissues. This breakthrough material could greatly improve orthopedic care by reducing complications, minimizing the need for additional surgeries, and providing a more sustainable alternative to permanent metallic implants.

“Our zinc alloy material could revolutionize orthopedic care – opening the door to safer, smaller implants that not only enhance patient comfort but also promote better healing outcomes by minimizing disruption to surrounding tissues,” said lead researcher, Professor Jian-feng Nie. “An implant that never disappears will always be a risk to the patient. On the other hand, one that degrades too fast won’t allow adequate time for the bones to heal. With our zinc alloy material, we can achieve the optimal balance between strength and controlled degradation of the implant to promote better healing.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.